MD, Gaithersburg, US
19 hours ago
Head of Lower Respiratory Tract Disease (LRTD)

When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of three days per week from the office. But that doesn't mean we're not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.

At AstraZeneca, we are redefining our future by thinking and acting differently. Our vision is to be the leader in Cardiovascular, Renal, Metabolism, Respiratory, and Immunology by 2025. We are forward-looking, challenge the status quo, reflect on insights, spot opportunities, and act on smart risks. Our BioPharmaceuticals pipeline is growing, and it takes something special to get that out to patients. We go above and beyond to find solutions that impact patients - harnessing science with technology and connecting the entire healthcare ecosystem. Every decision we make is centered around how we can better serve patients. Join a global team filled with diverse perspectives where everyone is empowered to share ideas openly.

Ready to make a difference? Apply now!

Introduction to role

Tozorakimab, a novel high affinity IL-33 antibody that is the first anti-IL-33 antibody suppressing activity of both IL-33red–ST2 and IL-33ox–RAGE/EGFR signalling pathways with potential for differentiated efficacy vs competitors.

Tozorakimab is being developed by AstraZeneca and is expected to be the leading anti-IL33 therapy with the broadest and most differentiated claim set in class​ and represents one of the top company priorities within the respiratory TA and the overall portfolio. Tozorakimab is expected to be the first to market in severe viral lower respiratory tract disease (LRTD)​.

Within the Respiratory Global Team and reporting to the commercial VP, Tozorakimab, you will be the strategy and launch lead for the LRTD indication. There are numerous studies underway to support the COPD indications and the expansion into the asthma market.

You will be accountable for the development and implementation of the commercial strategy and compelling promotional plans for this indication, up to and including, promotional communication materials, global campaign, global promotional activities, launch preparation workshops, sales support materials according to the brand strategy.  You will represent the commercial voice in the LRTD GPT (Global Product Team) providing input and contributing to the decision making on future clinical development projects.

The successful individual will demonstrate strong skills in the areas of strategic thinking, decision making, communication, leadership, problem solving and collaboration. 

Accountabilities

As the global Head of LRTD Tozorakimab, you will represent Global Commercial and be accountable for:

• Leading the LRTD commercial strategy definition.

• Representing the commercial LRTD voice within the global cross-functional product team.

• Leading the global LRTD commercial working group and Global Brand Team (GBT).

• Engaging with local heads of marketing to ensure flawless and aligned execution of the strategy.

• Engaging with Key External Experts (KEEs) to gather input to inform the LRTD strategy and activities plan, including advocacy development.

Essential Skills/Experience

• 10+ years’ experience in the biopharma industry, with a strong preference for experience in the hospital and acute care business.

• In-depth understanding of hospital and acute commercial strategy, account management, methodologies, and tools (product profiling and positioning, forecasting, pricing reimbursement, market research techniques, competitive intelligence resources).

• Thorough ‘hands-on’ knowledge of building Target Product Profiles (TPPs), generating sales forecasts, and business cases.

• Experience shaping brand strategy while understanding of product profile is evolving.

• Thorough understanding of the drug development process and the need for commercial line of sight throughout.

• Understanding of future healthcare market challenges including local regulatory requirements

• Exposure to and track record of effective management of senior decision-making/governance bodies.

• Proven experience engaging with and leveraging insights from external customers e.g., KEEs, prescribers, payors.

Desirable Skills/Experience

• Strong strategic thinking, decision making, and problem-solving skills.

• Strong leadership and influencing skills to ensure a strong commercial focus in R&D projects.

• Proven ability to collaborate across functional boundaries.

• Demonstrated ability to bring ideas to action.

• Strong analytical, organizational, and communication skills (written and verbal) required.

The annual base pay for this position ranges from $256,297 to $384,445. Hourly and salaried non-exempt employees will also be paid overtime pay when working qualifying overtime hours. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience.  In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program (salaried roles), to receive a retirement contribution (hourly roles), and commission payment eligibility (sales roles). Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans. Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base pay (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors. ​

Date Posted

07-Jan-2025

Closing Date

30-Jan-2025Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.
Confirm your E-mail: Send Email